What are ADMA Biologics's profit margins?

ADMA Biologics (ADMA) runs a 61.3% gross margin and a 42.1% operating margin, with a 32.4% net margin.

Where do ADMA Biologics's ratios come from?

Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

ADMA Biologics ADMA Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	61.3%+3.9pp	57.4%+2.7pp	54.7%+1.7pp	53%+0.4pp	52.6%+1.1pp
Operating margin	42.1%+4.6pp	37.5%+3.3pp	34.2%+1.4pp	32.8%-0.3pp	33.1%+0.5pp
Net margin	32.4%+3.6pp	28.8%-14.1pp	42.9%-1.2pp	44.1%-0.9pp	45%-1.3pp
EBITDA margin	43.7%+4.6pp	39.1%+3.3pp	35.8%+1.3pp	34.5%-0.3pp	34.8%+0.4pp
Free cash flow margin	21.2%+15.7pp	5.5%-2.9pp	8.3%-5.5pp	13.9%-5.9pp	19.7%-6.2pp
Returns
Return on equity	43.3%+7.7pp	35.6%-27.6pp	63.2%-8.1pp	71.2%-7.2pp	78.5%-3.2pp
Return on assets	28.1%+1.7pp	26.4%-17.3pp	43.7%-1.0pp	44.7%-3.3pp	48%-0.3pp
Return on invested capital	44.8%+6.2pp	38.6%-16.3pp	54.9%-17.7pp	72.6%+1.9pp	70.7%+4.9pp
Efficiency
Asset turnover	0.9×0.0×	0.9×-0.1×	1×0.0×	1×-0.1×	1.1×0.0×
Inventory turnover	1×-0.2×	1.2×0.0×	1.2×0.0×	1.2×0.0×	1.2×0.0×
Liquidity
Current ratio	7×+0.2×	6.7×-0.4×	7.1×+1.8×	5.3×-1.2×	6.6×+0.6×
Quick ratio	3.9×+0.2×	3.7×+0.1×	3.6×+0.9×	2.8×-0.6×	3.4×+0.5×
Cash ratio	1.9×+0.6×	1.3×+0.2×	1.1×-0.1×	1.2×-0.1×	1.3×-0.5×
Leverage
Debt-to-equity	0.5×+0.4×	0.2×0.0×	0.2×+0.2×	0×0.0×	0×-0.2×
Debt-to-assets	0.3×+0.2×	0.1×0.0×	0.1×+0.1×	0×0.0×	0×-0.1×
Net debt / EBITDA	0.3×+0.3×	-0×-0.2×	0.1×+0.6×	-0.5×-0.1×	-0.4×-0.2×
Interest coverage	29.7×+2.8×	26.9×+7.0×	20×+4.7×	15.3×+2.8×	12.5×+2.6×
Per Share
Book value per share	$1.63-16.5%	$1.95+10.6%	$1.76+10.0%	$1.60+5.0%	$1.53+6.4%
Valuation
Market capitalization	$2.15B-50.6%	$4.34B+24.1%	$3.5B-17.9%	$4.26B-9.6%	$4.71B+16.3%
Enterprise value	$2.21B-49.0%	$4.33B+23.1%	$3.52B-15.8%	$4.18B-10.1%	$4.65B+15.4%
Price / earnings	13×-16.6×	29.5×+12.8×	16.7×-3.7×	20.4×-2.4×	22.8×+2.3×
Price / sales	4.2×-4.3×	8.5×+1.3×	7.2×-1.8×	9×-1.3×	10.3×+0.8×
Price / book	5.5×-3.6×	9.1×+1.0×	8.1×-2.6×	10.7×-1.9×	12.6×+1.0×
EV / EBITDA	9.9×-11.8×	21.7×+1.6×	20.1×-5.5×	25.6×-3.5×	29.1×+1.6×
EV / sales	4.3×-4.2×	8.5×+1.3×	7.2×-1.6×	8.8×-1.3×	10.1×+0.7×
Free cash flow yield	5%+4.4pp	0.6%-0.5pp	1.2%-0.4pp	1.5%-0.4pp	1.9%-0.8pp
Earnings yield	7.7%+4.3pp	3.4%-2.6pp	6%+1.1pp	4.9%+0.5pp	4.4%-0.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are ADMA Biologics's profit margins?: ADMA Biologics (ADMA) runs a 61.3% gross margin and a 42.1% operating margin, with a 32.4% net margin.
Where do ADMA Biologics's ratios come from?: Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.